2-[6-(3-Chlorophenyl)-2,4-dioxo-perhydropyrimidin-3-yl]ethyl morpholine-4-carbodithioate

Acta Crystallographica Section C: Crystal Structure Communications

Volumn 60, Issue 10, 2004, Pages

  Köysal, Yavuz ^a   Lşik, Sa̧mil ^a   Septiog̃lub, Ebubekir ^b   Çaliş, Ünsal ^b  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BENZENE; COMPUTATIONAL GEOMETRY; CRYSTAL STRUCTURE; DERIVATIVES; DRUG THERAPY; FUNGI; HYDROGEN BONDS; MOLECULAR STRUCTURE; PROBABILITY; SYNTHESIS (CHEMICAL); TOXICITY; TUMORS;

ANTICONVULSANT THERAPY; ELEMENTAL ANALYSIS; MORPHOLINE RING; PUCKERING AMPLITUDE;

ORGANIC COMPOUNDS;

2 (6 (3 CHLOROPHENYL) 2,4 DIOXOPERHYDROPYRIMIDIN 3 YL)ETHYL MORPHOLINE 4 CARBODITHIOATE; 2-(6-(3-CHLOROPHENYL)-2,4-DIOXOPERHYDROPYRIMIDIN-3-YL)ETHYL MORPHOLINE-4-CARBODITHIOATE; ANTICONVULSIVE AGENT; DISULFIDE; MORPHOLINE DERIVATIVE;

ARTICLE; CHEMISTRY; CONFORMATION; HYDROGEN BOND; X RAY CRYSTALLOGRAPHY;

ANTICONVULSANTS; CRYSTALLOGRAPHY, X-RAY; DISULFIDES; HYDROGEN BONDING; MOLECULAR CONFORMATION; MORPHOLINES;

BACTERIA (MICROORGANISMS); FUNGI;

EID: 8344228490     PISSN: 01082701     EISSN: None     Source Type: Journal    
DOI: 10.1107/S0108270104018852     Document Type: Article

References (22)

1. Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1981). J. Chem. Soc. Perkln Trans. 2, pp. S1-19.
2. Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P. & Perucca, E. (2002). Epilepsy Res. 51, 31-71.
3. Brodie, M. J. (2001). Epilepsy Res. 45, 3-6.
4. Burnett, M. N. & Johnson, C. K. (1996). ORTEPIII. Report ORNL-6895. Oak Ridge National Laboratory, Tennessee, USA.
5. Çaliş, Ü. & Köksal, M. (2001). Arzneim. Forsch. (Drug Res.), 51, 523-528.
6. Çaliş, Ü., Özkanli, F., Dalkara, S., Erol, K. & Özdemir, M. (1993). Pharmazie, 48, 945-946.
7. Chabric, P., Maillard, G. & Quevauviller, A. (1956). Ann. Pharm. Fr. 14, 720-728.
8. Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
9. Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
10. Guillon, J., Daoust, M., Radulovic, D., Boulouard, M., Dallemagne, P., Legrand, E., Rault, S., Quermonne, M. A. & Robba, M. (1996). Eur. J. Med. Chem. 31, 335-339.
11. Gupta, S. P. & Garg, D. M. L. (1965). J. Indian Chem. Soc. 42, 412-414.
12. Kumar, B. V. & Reddy, V. M. (1985). Indian J. Chem. Sect. B, 24, 1298-1301.
13. Nardelli, M. (1995). J. Appl. Cryst. 28, 659.
14. Özalp, M., Çaliş, Ü. & Köksal, M. (2000). Hacettepe Univ. J. Fac. Pharm. 20, 37-44.
15. Ramrakhyani, A. K. & Shukla, R. S. (1980). J. Indian Chem. Soc. 57, 856-857.
16. Sanyal, U., Mitra, S., Pal, P. & Chakraborti, S. K. (1986). J. Med. Chem. 29, 595-599.
17. Septiog̃lu, E., Aytemir, M. D. & Çaliş, Ü. (2004). Arzneim. Forsch. (Drug Res.). In the press.
18. Sheldrick, G. M. (1997). SHELXS97 and SHELXL97. University of Göttingen, Germany.
19. Skulnick, H. I., Ludens, J. H., Wendung, M. G., Glenn, E. M., Rohloff, N. A. & Smith, R. J. (1986). J. Med. Chem. 29, 1499-1504.
20. Stoe & Cie (2002). X-AREA (Version 1.18) and X-RED32 (Version 1.04). Stoe & Cie, Darmstadt, Germany.
21. Weuffen, W. & Kewitsch, A. (1967). Arch. Exp. Veterinaermed. 21, 1049-1059.
22. Zsolnai, T. (1968). Anzeim, Forsch. 18, 1319-1324.